LaTonya J. Hickson
Chair, Division of Nephrology & Hypertension, Department of Internal Medicine · Mayo Clinic
Credentials: · · · ·
History
- Present
Research
EBioMedicine · 2019 · First of 33 authors · 1,102 citations
Cellular senescence: the good, the bad and the unknown
Review · Nature Reviews Nephrology · 2022 · 960 citations
A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
Nature Communications · 2022 · 875 citations
31 papers · 9 as a fellow
17 papers
16 papers
14 papers
14 papers
- XZ
14 papers
13 papers
10 papers
Grants
- 2023–2028
Extracellular Vesicle-Based Senotherapeutics for Aging Diabetic Kidneydisease
National Institute on Aging · R01
Contact PI · $2.3M · Mayo Clinic Jacksonville
- 2020–2023
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $466.8K · Mayo Clinic Jacksonville
- 2016–2022
Mesenchymal Stem Cell Senescence in Diabetic Nephropathy (K23 COVID Admin Supplement)
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $1M · Mayo Clinic Jacksonville
Clinical trials
- 2024–2031
Principal investigator · Recruiting
Mayo Clinic
- 2022–2024
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
Principal investigator · Completed · Phase 1
LaTonya J. Hickson
- 2021–2023
Stem Cell Therapy for Chronic Kidney Disease
Principal investigator · Completed · Phase 1
LaTonya J. Hickson
- 2019–2020
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
Principal investigator · Terminated · Phase 1
Mayo Clinic